← All Companies
CITIUS ONCOLOGY, INC.
CTOR · Nasdaq · SIC 2834: Pharmaceutical Preparations
Business Summary PART I Business Overview The Company, headquartered in Cranford, New Jersey, is a biopharmaceutical company focused on developing and commercializing innovative targeted oncology therapies. The Companys strategy centers on achieving a market leading position by advancing innovative therapies with reduced development and clinical risks, and competitive advantages supported by intellectual property and regulatory exclusivity protection. This includes new formulations of previously approved drugs w...
Next Earnings Q2 FY2026 — expected 2026-09-14
Key Facts from Earnings Calls Type Subject Detail Quarter topic_mention CTOR discussed_in_filing Artificial Intelligence topic_mention CTOR discussed_in_filing Cybersecurity topic_mention CTOR discussed_in_filing Trusted Computing topic_mention CTOR discussed_in_filing Blockchain & Crypto topic_mention CTOR discussed_in_filing Regulation topic_mention CTOR discussed_in_filing Healthcare & Bio topic_mention CTOR discussed_in_filing Platform & Ecosystem topic_mention CTOR discussed_in_filing Artificial Intelligence topic_mention CTOR discussed_in_filing Cybersecurity topic_mention CTOR discussed_in_filing Trusted Computing topic_mention CTOR discussed_in_filing Blockchain & Crypto topic_mention CTOR discussed_in_filing Regulation topic_mention CTOR discussed_in_filing Healthcare & Bio topic_mention CTOR discussed_in_filing Platform & Ecosystem topic_mention CTOR discussed_in_filing Artificial Intelligence topic_mention CTOR discussed_in_filing Cybersecurity topic_mention CTOR discussed_in_filing Trusted Computing topic_mention CTOR discussed_in_filing Blockchain & Crypto topic_mention CTOR discussed_in_filing Regulation topic_mention CTOR discussed_in_filing Healthcare & Bio
Annual Reports (10-K) Filed Period Accession Source Full Text 2025-12-23 2025-09-30 0001213900-25-125331 EDGAR 61K words 2024-12-27 2024-09-30 0001213900-24-113150 EDGAR — 2024-04-16 2023-12-31 0001493152-24-014850 EDGAR — 2023-04-17 2022-12-31 0001493152-23-012545 EDGAR —
Quarterly Reports (10-Q) Filed Period Accession Source Full Text 2026-02-13 2025-12-31 0001213900-26-015877 EDGAR 15K words 2025-08-12 2025-06-30 0001213900-25-074992 EDGAR — 2025-05-14 2025-03-31 0001213900-25-043359 EDGAR — 2025-02-14 2024-12-31 0001213900-25-014320 EDGAR — 2024-08-09 2024-06-30 0001493152-24-030991 EDGAR — 2024-05-20 2024-03-31 0001493152-24-020783 EDGAR — 2023-11-20 2023-09-30 0001493152-23-042170 EDGAR — 2023-08-16 2023-06-30 0001493152-23-029131 EDGAR — 2023-05-15 2023-03-31 0001493152-23-017394 EDGAR — 2022-11-28 2022-09-30 0001493152-22-033847 EDGAR —
Recent Current Reports (8-K) Filed Accession Source Full Text 2026-03-31 0001213900-26-037501 EDGAR 3K words 2026-03-10 0001213900-26-025464 EDGAR — 2026-03-04 0001213900-26-023440 EDGAR — 2026-02-13 0001213900-26-015894 EDGAR — 2025-12-23 0001213900-25-125418 EDGAR — 2025-12-10 0001213900-25-120197 EDGAR — 2025-12-01 0001213900-25-116764 EDGAR — 2025-10-27 0001213900-25-102625 EDGAR — 2025-10-23 0001213900-25-101737 EDGAR — 2025-09-19 0001213900-25-089615 EDGAR —
75 total filings indexed. 51 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
Sector Peers Company Identity
CIK 0001851484
Ticker CTOR
Exchange Nasdaq
SIC 2834: Pharmaceutical Preparations
Incorporated DE
Get More Data
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile
Stock Quote
AI Readiness Report
Origin Provenance
page leaf: c2ddd0a5dd7a69f39450a0c803f16b579a4e67bb1efec005cd88dd68a89b1038
parent: eff2d9eaa794f7b2fc987ed5ef2cd6180e335c35684ece6031b0282ddac12401
content hash: 841ff9101328e428d6993e4ef27d6b8dd3a034cd6238ff1a2e0eedf93090333e
signed: 2026-04-13T04:44:32.390Z
sources: 14 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf